Scarica l'app Stockscreener
510.13
1.26%
-6.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$516.62
Aprire:
$510.85
Volume 24 ore:
1.71M
Relative Volume:
0.75
Capitalizzazione di mercato:
$189.58B
Reddito:
$45.20B
Utile/perdita netta:
$6.87B
Rapporto P/E:
28.05
EPS:
18.1888
Flusso di cassa netto:
$6.75B
1 W Prestazione:
-0.62%
1M Prestazione:
+8.62%
6M Prestazione:
-15.89%
1 anno Prestazione:
+19.70%
Intervallo 1D:
$507.00
$512.96
Intervallo di 1 settimana:
$506.82
$529.15
Portata 52W:
$403.36
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, NTRA, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
510.13 | 189.58B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
190.77 | 135.02B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
555.67 | 43.83B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
274.39 | 39.30B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
129.07 | 36.45B | 7.23B | 1.41B | 1.09B | 4.979 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market - MarketWatch
Thermo Fisher expands its scientific footprint as investors assess long-term growth - Ad-hoc-news.de
Thermo Fisher Scientific Launches GENESYS G5 UV-Visible Spectrophotometer Series - Food Safety Magazine
Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG - PR Newswire
Thermo Fisher's Patheon becomes exclusive third-party CDMO for KinetiSol technology - Manufacturing Chemist
Thermo Fisher (TMO) Wins FBI Approval For Rapid DNA Tool In Crime Investigations - Yahoo Finance
Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026 - AOL.com
Thermo Fisher Scientific Launches New Quality Assurance Software - Clinical Lab Products
Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches - Business Wire
TMO Maintained by Evercore ISI Group -- Price Target Lowered to $570 - GuruFocus
Thermo Fisher Scientific Inc. stock falls Monday, underperforms market - MarketWatch
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $570 From $575 - marketscreener.com
Thermo Fisher Scientific Inc (TMO) Stock Analysis: Evaluating The 13.91% Potential Upside - DirectorsTalk Interviews
Environmental DNA Market Set to Surge to USD 5.61 Billion by 2031 with 10.2% CAGR - GlobeNewswire Inc.
Shapiro Administration Highlights the Need for Funding to Grow Pennsylvania’s Innovation Economy During Visit to Thermo Fisher Scientific in Dauphin County - PA Department of Community & Economic Development (.gov)
Thermo Fisher launches LabLink 360 software to streamline QC review workflows - Select Science
Kavaljer Investmentbolagsfond June 2026 – Thermo Fisher and Siemens New Holdings - marketscreener.com
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Arcturus Therapeutics Announces Strategic Collaboration With Thermo Fisher Scientific - TradingView
Thermo Fisher to back Arcturus (NASDAQ: ARCT) ARCT-032 Phase 3 and manufacturing - Stock Titan
Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis - Business Wire
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher NanoDrop OneC from Thermo Fisher Scientific Inc.compact UV-Vis spectrophotometer po - AD HOC NEWS
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026 - BioSpace
Press Release: Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026 - Moomoo
Form 4 Thermo Fisher Scientific For: 30 June By Investing.com - Investing.com Canada
Thermo Fisher (NYSE: TMO) director awarded new phantom stock units as deferred pay - Stock Titan
Thermo Fisher (TMO) director adds phantom stock units via deferred pay grant - Stock Titan
Thermo Fisher (NYSE: TMO) director awarded new phantom stock units - Stock Titan
Thermo Fisher (NYSE: TMO) director defers fees into phantom stock units - Stock Titan
Thermo Fisher (TMO) director receives phantom stock unit award under deferred plan - Stock Titan
Thermo Fisher Scientific’s PPD Clinical Research Business Collabo - The National Law Review
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration - 01net
Thermo Fisher Scientific Expands HLA-DQ Testing Coverage for Transplant Antibody Assessment - Clinical Lab Products
Thermo Fisher Scientific Earnings Preview: What to Expect - Yahoo Finance
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion - MSN
Genedrive Teams Up with Thermo Fisher Scientific to Develop Laboratory-based Genetic Test - marketscreener.com
genedrive shares climb 8% on Thermo Fisher pharmacogenetic testing deal - Proactive Investors
Genedrive Partners with Thermo Fisher to Expand CYP2C19 Diagnostic Portfolio (GDR) - Yahoo Finance UK
Thermo Fisher Scientific: Gradually Getting Cheaper - Seeking Alpha
REGGenedrive PLCCYP2C19 Agreement with Thermo Fisher Scientific - TradingView
Thermo Fisher Scientific Inc.(NYSE: TMO) added to Russell 1000 Dynamic Index - marketscreener.com
Thermo Fisher outlines capital plans for 2030, shares tracked against S&P 500 peers - Ad-hoc-news.de
Bernstein Says Life Science Sector is Improving, Resumes Thermo Fisher Scientific (TMO) Coverage - Insider Monkey
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMOD) - TradingView
The Axion M200 from Thermo Fisher Scientific Inc.compact microscope for crowded benchtops - Ad-hoc-news.de
Thermo Fisher extends its diagnostics reach, shares supported by strong S&P 500 positioning - Ad-hoc-news.de
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMOC) - TradingView
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MarketWatch
Bernstein SocGen resumes Thermo Fisher stock coverage with market perform - Investing.com
Thermo Fisher (TMO) Coverage Resumed with Market Perform Rating and $520 Target - GuruFocus
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):